| Year |
Citation |
Score |
| 2020 |
Wang Z, Li Y, Wang Y, Wu D, Lau AHY, Zhao P, Zou C, Dai Y, Chan FL. Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells. Stem Cell Research & Therapy. 11: 123. PMID 32183880 DOI: 10.1186/S13287-020-01634-6 |
0.395 |
|
| 2019 |
Zhao P, Zhou W, Liu C, Zhang H, Cheng Z, Wu W, Liu K, Hu H, Zhong C, Zhang Y, Zhou D, Liu F, Dai Y, Wang J, Zou C. Establishment and Characterization of a CTC Cell Line from Peripheral Blood of Breast Cancer Patient. Journal of Cancer. 10: 6095-6104. PMID 31762819 DOI: 10.7150/Jca.33157 |
0.382 |
|
| 2019 |
Liu K, Dong F, Gao H, Guo Y, Li H, Yang F, Zhao P, Dai Y, Wang J, Zhou W, Zou C. Promoter hypermethylation of the CFTR gene as a novel diagnostic and prognostic marker of breast cancer. Cell Biology International. PMID 31721358 DOI: 10.1002/Cbin.11260 |
0.353 |
|
| 2019 |
Dai W, Zhou F, Tang D, Lin L, Zou C, Tan W, Dai Y. Single-cell transcriptional profiling reveals the heterogenicity in colorectal cancer. Medicine. 98: e16916. PMID 31441872 DOI: 10.1097/Md.0000000000016916 |
0.34 |
|
| 2019 |
Ma J, Sun G, Zhu P, Liu S, Ou M, Chen Z, Zou C, Chan FL, Dai Y, Sui W. Determination of the complexity and diversity of the TCR β-chain CDR3 repertoire in bladder cancer using high-throughput sequencing. Oncology Letters. 17: 3808-3816. PMID 30881501 DOI: 10.3892/Ol.2019.10015 |
0.363 |
|
| 2019 |
Zhao P, Zhang H, Liu C, Wang J, Zhou W, Zou C. Abstract 3982: Isolation, culture & characterization ofthe circulating tumor cells from breast cancer patients’ peripheral bloodin vitro Cancer Research. 79: 3982-3982. DOI: 10.1158/1538-7445.Am2019-3982 |
0.388 |
|
| 2018 |
Gao W, Wu D, Wang Y, Wang Z, Zou C, Dai Y, Ng CF, Teoh JY, Chan FL. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells. Stem Cell Research & Therapy. 9: 243. PMID 30257704 DOI: 10.1186/S13287-018-0987-X |
0.323 |
|
| 2018 |
Xiao L, Wang Y, Liang W, Liu L, Pan N, Deng H, Li L, Zou C, Chan FL, Zhou Y. LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21. Cancer Management and Research. 10: 2389-2400. PMID 30122988 DOI: 10.2147/Cmar.S162887 |
0.32 |
|
| 2018 |
Xu Z, Wang Y, Xiao ZG, Zou C, Zhang X, Wang Z, Wu D, Yu S, Chan FL. Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer. Oncogene. PMID 30042415 DOI: 10.1038/S41388-018-0409-7 |
0.391 |
|
| 2018 |
Jia L, Wu D, Wang Y, You W, Wang Z, Xiao L, Cai G, Xu Z, Zou C, Wang F, Teoh JY, Ng CF, Yu S, Chan FL. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Oncogene. PMID 29555975 DOI: 10.1038/S41388-018-0198-Z |
0.392 |
|
| 2018 |
Zhao P, Zou C, Hu H, Zhong Cn, Zhang Yy, Zhou Dx, Zhou Wb. Establishment and characterization of a circulating tumor cell line from a breast cancer patient. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E13062 |
0.311 |
|
| 2016 |
Li X, Wu WX, Zhang CM, Zhang A, Luo YP, Zhang ZW, Deng RJ, Zou C, Meng T. Fabrication and characterization of planar luminescent solar concentrator waveguides based on LR305 dye Guang Pu Xue Yu Guang Pu Fen Xi/Spectroscopy and Spectral Analysis. 36: 1001-1006. DOI: 10.3964/j.issn.1000-0593(2016)04-1001-06 |
0.384 |
|
| 2015 |
Wu D, Yu S, Jia L, Zou C, Xu Z, Xiao L, Wong KB, Ng CF, Chan FL. Orphan nuclear receptor TLX functions as a potent suppressor of oncogene-induced senescence in prostate cancer via its transcriptional co-regulation of the CDKN1A (p21(WAF1) (/) (CIP1) ) and SIRT1 genes. The Journal of Pathology. 236: 103-15. PMID 25557355 DOI: 10.1002/Path.4505 |
0.423 |
|
| 2014 |
Yu S, Xu Z, Zou C, Wu D, Wang Y, Yao X, Ng CF, Chan FL. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization. The Journal of Pathology. 234: 514-25. PMID 25065497 DOI: 10.1002/Path.4413 |
0.379 |
|
| 2014 |
Zou C, Yu S, Xu Z, Wu D, Ng CF, Yao X, Yew DT, Vanacker JM, Chan FL. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. The Journal of Pathology. 233: 61-73. PMID 24425001 DOI: 10.1002/Path.4329 |
0.552 |
|
| 2012 |
Ma X, Cai Y, He D, Zou C, Zhang P, Lo CY, Xu Z, Chan FL, Yu S, Chen Y, Zhu R, Lei J, Jin J, Yao X. Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 16282-7. PMID 22988121 DOI: 10.1073/Pnas.1202989109 |
0.343 |
|
| 2011 |
Yu S, Zhang Y, Yuen MT, Zou C, Danielpour D, Chan FL. 17-Beta-estradiol induces neoplastic transformation in prostatic epithelial cells. Cancer Letters. 304: 8-20. PMID 21353741 DOI: 10.1016/J.Canlet.2011.01.003 |
0.348 |
|
| 2011 |
Zou C, Yu S, Yew DT, Chan FL. Abstract 4543: Nuclear receptor estrogen-related receptor alpha promotes hypoxic growth prostate cancer cells Endocrinology. 71: 4543-4543. DOI: 10.1158/1538-7445.Am2011-4543 |
0.343 |
|
| Show low-probability matches. |